ABOS β€” ACUMEN PHARMACEUTICALS INC

Ownership history in CATALYST FINANCIAL PARTNERS LLC  Β·  11 quarters on record

AI Ownership Summary

CATALYST FINANCIAL PARTNERS LLC reported ACUMEN PHARMACEUTICALS INC (ABOS) in 11 quarterly 13F filings from 2023 Q3 through 2025 Q4. Peak portfolio weight reached 0.12% in 2023 Q3. The latest visible filing shows ABOS at 0.02% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this ABOS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was CATALYST FINANCIAL PARTNERS LLC's position in ACUMEN PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ABOS was reported at 0.02% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.12% in 2023 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q3 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How CATALYST FINANCIAL PARTNERS LLC held ABOS β€” position size vs. price
% of Fund (quarterly)    ABOS price (quarter-end, indexed to 100)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 UNCHANGED 89,699 β€” 0% 0.02% $189K 2026-02-14 (Est.) $2.51
2025 Q3 UNCHANGED 89,699 β€” 0% 0.02% $153K 2025-11-12 $1.95
2025 Q2 UNCHANGED 89,699 β€” 0% 0.01% $104K 2025-08-14 $1.40
2025 Q1 UNCHANGED 89,699 β€” 0% 0.02% $99K 2025-05-02 $1.08
2024 Q4 UNCHANGED 89,699 β€” 0% 0.03% $154K 2025-01-30 $1.56
2024 Q3 UNCHANGED 89,699 β€” 0% 0.04% $222K 2024-10-28 $2.89
2024 Q2 UNCHANGED 89,699 β€” 0% 0.05% $217K 2024-07-25 $3.41
2024 Q1 UNCHANGED 89,699 β€” 0% 0.08% $311K 2024-04-23 $3.16
2023 Q4 UNCHANGED 89,699 β€” 0% 0.10% $344K 2024-02-07 $3.14
2023 Q3 UNCHANGED 89,699 β€” 0% 0.12% $372K 2023-10-26 $3.22
1 older quarter hidden  β€”  Sign in free or upgrade to Premium to see full history

FAQ About CATALYST FINANCIAL PARTNERS LLC and ABOS

These are the practical questions this page is built to answer before you even open the full history table.

How long has CATALYST FINANCIAL PARTNERS LLC reported owning ABOS?

CATALYST FINANCIAL PARTNERS LLC reported ABOS across 10 quarterly 13F filings, from 2023 Q3 through 2025 Q4.

What was the largest reported ABOS position in CATALYST FINANCIAL PARTNERS LLC's portfolio?

The largest reported portfolio weight for ABOS was 0.12% in 2023 Q3.

What is the latest reported ABOS position on this page?

The most recent filing on this page is 2025 Q4, when CATALYST FINANCIAL PARTNERS LLC reported 89,699 shares, equal to 0.02% of portfolio, with an estimated market value of $189K.

What does the chart on this ABOS ownership page compare?

The chart compares CATALYST FINANCIAL PARTNERS LLC's quarterly ABOS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to CATALYST FINANCIAL PARTNERS LLC Holdings